Biotech

All Articles

Genentech to shut cancer cells immunology research team

.Genentech will certainly shut its own cancer immunology research study division, as well as device ...

Kezar goes down sound growth however to verify its truly worth in stage 1 trial

.Kezar Lifestyle Sciences is falling its dim phase 1 solid cyst drug as the biotech goes all-in on i...

Acelyrin loses izokibep, dismisses 3rd of staff

.Despite izokibep maintaining its newfound winning streak in the center, Acelyrin is actually no lon...

Rivus' phase 2 obesity-related cardiac arrest test reaches endpoint

.Rivus Pharmaceuticals has plumped up the potential customers of its own fat-busting, muscle-sparing...

Ovid halts preclinical work, IV program after soticlestat fall short

.Ovid Therapy actually disclosed final month that it was actually trimming its head count as the com...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston Port

.Eli Lilly has opened up a $700 thousand R&ampD center in the Boston Seaport, enhancing its RNA and ...

Boundless Biography helps make 'modest' discharges five months after $100M IPO

.Just 5 months after safeguarding a $100 thousand IPO, Limitless Biography is actually presently lay...

Halda's $126M will certainly accelerate 'secure and also kill' cyst medications

.The preliminary stages of oncology R&ampD aren't except interesting brand-new methods, and Halda Re...

Lykos 'disappointments' certainly not disclosing research study transgressions along with publisher

.Psychopharmacology has drawn 3 short articles concerning midstage scientific test data analyzing Ly...

Analysts examine Avidity's DMD win, disclosing nuances in records

.Avidity Biosciences amazed clients along with stage 1/2 records in Duchenne muscular dystrophy (DMD...